Anp has been devalued like most stocks in the Biotech sector....Nasdaq.
Anp has built a pipeline with 2 drugs in late stage.
Anp has $5 mill in the Bank with Orphan Designation for Acromegaly being granted in the next 4 weeks...
Anp ,only now with a good story re 2 drugs in late stage..something to sell to INVESTORS ..brought on board x2 big gun Directors from the Nasdaq with great Biotech EXPERIENCE.
Anp in the next 2 months will be in a better position to put us on the World Biotech Map.Canges are coming within the Coy.
Diamond and the Board are in the slow process of building a biotech Coy...
Critics unfair on Diamond and Board.
-
- There are more pages in this discussion • 72 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $66.71M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 6766 | 7.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.7¢ | 29288 | 1 |
View Market Depth
| Last trade - 10.59am 26/07/2024 (20 minute delay) ? |
| PER (ASX) Chart |
Day chart unavailable